PHASE Scientific is a high-growth biotech company founded by bioengineers from UCLA. We build tools that empower people by giving them better information about their health. Now headquartered in Hong Kong, our global footprint includes R&D and manufacturing facilities in Southern
California and offices in Mainland China.



We endeavor to support patients and healthcare providers through the creation of innovative diagnostic and data tools that enable people to better understand their own health.


We believe everyone deserves access to the best knowledge about their health, and that higher quality information in the hands of more people leads to better decision-making.

PHASE Scientific is built on a
new thinking and greater impact


As a patent attorney with a law practice in New York, Dr. Chan has assisted Nobel Prize winners, scientists, and start-ups obtain intellectual property protection and enforcement. With over 30 years of experience in IP law and a background in molecular biology, he uniquely meets the needs of the biotechnology industry. Beyond IP protection, Dr. Chan also has a great deal of experience in transactional work in licensing, joint ventures, and public listings. He currently holds Adjunct Professorship at several universities in Hong Kong.

Professor Featherstone is an expert in cariology (the study of tooth decay), and the founder of Caries Management by Risk Assessment (CAMBRA), a tool for understanding a patient’s risk in getting tooth decays.

He has won many awards for his work, including the Norton Ross Award for excellence in clinical research from the American Dental Association (2007), the Zsolnai Prize from the European Caries Research Organization (2002) for his lifelong contributions to caries research, and the Ericsson Prize in Preventive Dentistry by the Swedish Patent Fund (2002).

He is former Professor of Preventive and Restorative Dental Sciences at the University of California, San Francisco (UCSF) and Dean Emeritus of the UCSF School of Dentistry.

Mr. Jiang is a proven leader of the bioengineering and medical device industries in China. Combining his clinical training with business acumen, he has transformed and grown scores of companies through direct involvement and board membership.

In addition to advising companies, he also works to further the development of the industry. Among many positions in industry associations and the Government, he is Executive Vice President of the China Medical Device Industry Association, President of the National Medical Device Industry Innovation Strategic Alliance of the Ministry of Science and Technology, and Deputy Director of the Biomedical Engineering Education Steering Committee of the Ministry of Education.

Dr. Kamei is currently a Professor in the Department of Bioengineering at the University of California, Los Angeles (UCLA). He joined the faculty in 2003, and his research in paper microfluidic concentration has significantly impacted the core technology of PHASE. His work aims to continue to develop new technology to push the frontiers of diagnostics.

Professor Kamei has received multiple research awards, including the Coulter Early Career Award and the Kimmel Scholar Award. In addition to his research, Professor Kamei is also a dedicated teacher, and has been recognized by multiple teaching awards at UCLA, including the UCLA Academic Senate Distinguished Teaching Award and the Lockheed Martin Excellence in Teaching Award.

Professor Klausner is an international expert in the prevention and control of infectious diseases, particularly of HIV, sexually transmitted diseases (STDs) and tuberculosis (TB). He is a frequent advisor to the Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the World Health Organization.

Professor Klausner was previously Director of STD Prevention and Control for the San Francisco Department of Public Health. He was also the Branch Chief for HIV and TB for CDC in Pretoria, South Africa, where he helped lead The United States President’s Emergency Plan for AIDS Relief program there. He is a Professor of Medicine in the Division of Infectious Diseases and the Program in Global Health at the University of California, Los Angeles.

Professor Tam is a pioneer in the biotechnology and diagnostics industry in Hong Kong. He has retired from the Faculty of Medicine at the University of Hong Kong, having spent over three decades in teaching and research.

He is the Founder and President of the Hong Kong Biochemistry Association. He is an Honorary Associate Professor of the Li Ka Shing Faculty of Medicine, Hong Kong University, and a Visiting Professor at the University of California San Francisco, Baylor Medical College and the Medical College of Georgia. He is also the Founder and Chairman of DiagCor Bioscience Incorporation Limited.

A practicing clinician and biomaterial scientist, Professor Wu brings together expertise in multiple disciplines to provide patient care and develop solutions for unmet needs.

At the University of California, Los Angeles (UCLA), he is currently Professor and Chairman of the Division of Advanced Prosthodontics at the School of Dentistry, and Director of the Weintraub Center for Reconstructive Biotechnology. He is also Professor and past Chairman of Bioengineering and of Materials Science at the School of Engineering, and Professor of Orthopedic Surgery at the School of Medicine.

He serves on numerous advisory boards for government, academia and industry, and is also a fellow of the Academy of Prosthodontics.

Ricky CHIU, Ph.D.

Chairman & Chief Executive Officer

As Chairman and C.E.O., Ricky sets the vision and strategic direction of PHASE Scientific, and leads all of its fundraising effort.

As the lead inventor of the company’s core technology, he founded PHASE Scientific with the goal of realizing the potential of the technology, which he developed while completing his Ph.D. in bioengineering at the University of California, Los Angeles.


Chief Technology Officer

Dan provides overall direction in R&D for PHASE Scientific.

An industry veteran who was formerly Senior Vice President, Chief Scientific Officer and President of Greater China of Perkin Elmer (NYSE: PKI), Dan holds a number of board directorships, including InVivo Therapeutics (NASDAQ: NVIV) and Upside Biotechnologies. He is also Chief Scientific Officer of Ferghana Partners and Advisor at 5AM Ventures.

Dan earned his Ph.D. from Rockefeller University.

Leslie CHOW

Chief Financial Officer

Leslie oversees financial planning and risk management at PHASE Scientific.

Bing LIU

Chief People Officer

Bing leads people strategies and global organization design as HRBP at PHASE Scientific.

She has a wealth of global HR leadership expertise from serving in well-known multinational companies for 20+ years, along with national, regional and global HR leadership experience in consumer, hi-tech and medical device industries.

Bing holds an MBA from the University of Waikato, New Zealand.

Olivia CHAN

Quality & Compliance

Olivia leads global regulatory and market clearance at PHASE Scientific, and establishes quality policies, strategies and objectives for the company.

She has over 15 years of experience in U.S. FDA and global regulatory requirements and compliance. She is an American Society of Quality (ASQ) Certified Quality Auditor, is Yellow Belt Lean Six Sigma Certified, and is also accredited by the Certified Regulatory Affairs and Compliance Management.

Olivia received her B.S. from the University of California, Irvine.

Felix CHAO

Business Development

Felix is in charge of all business development at PHASE Scientific.

He was formerly Head of Global Project Management at SciClone Pharmaceuticals.

Felix completed his B.S. at the University of California, Los Angeles.

Kent CHENG, Ph.D.

Product Management

Kent is responsible for product management at PHASE Scientific.
He has extensive experience on project & new products management,  formulating new product pipeline and strategy, along with over 20 years of experience working in various multinational fine-chemicals and biotech corporations and research institutes.
Kent received his PhD from the Chinese University of Hong Kong.

Linda JIN


Linda oversees corporate branding and marketing strategies at PHASE Scientific.

She has over 20 years of experience in both B2C and B2B marketing, and had held senior management positions in a number of well-known multinational corporations.

Linda received her MBA from Jinan University.



Lana oversees manufacturing at the U.S. operation of PHASE Scientific.

She has over 10 years of experience in technical roles, leading product, process and manufacturing functions, including working on product launches, process improvements, and in manufacturing of point-of-care tests.

Lana holds a B.S. degree from the University of California, Irvine, majoring in chemistry with a minor in biological sciences.

Simon LI


Simon oversees business in China including sales, product marketing and business development at PHASE Scientific.

He brings 10 years of genomics industry experience in sales and business development. Simon was previously responsible for developing markets in South China, South Korea, and Australia.
Simon received his MS from Hunan Agricultural University.

Garrett MOSLEY, Ph.D.

Research & Development

Garrett leads PHASE Scientific’s operations and R&D effort in the U.S.

He earned his Ph.D. from the University of California, Los Angeles.



Tom leads US commercial strategies at PHASE Scientific.
Tom brings to Phase Scientific more than 20 years of diagnostics expertise in significant executive leadership roles in both startup and large-scale organizations. Prior to Phase, Tom led a California biotechnology startup company from zero revenue to profitability.
Tom holds a Bachelor of Science degree in Political Science